Nonprofits›Scleroderma Clinical Trials Consortium Inc
Medical Research
Scleroderma Clinical Trials Consortium Inc
BOSTON, MA
Total revenue
$326K
Total expenses
$299K
Net assets
$4.0M
Grants received
—
EIN
043543489
Tax year
2024
Mission
To foster scientific research and to advance medical research in the form of treatment trials in scleroderma on a worldwide basis.
Financials
FY 2024
Revenue
Contributions & grants$217K
Program service revenue—
Investment income$109K
Other revenue—
Total revenue$326K
Expenses
Grants paid$222K
Salaries & benefits—
Fundraising—
Other expenses$76K
Total expenses$299K
Total assets$4.0M
Net assets$4.0M
People
4 listed
NameRoleCompensation
ROBYN THERESE DOMSIC-DEGAZIO
PRESIDENT
Board
—
TRACY FRENCH
VICE PRESIDE
Board
—
JERRY A MOLITOR
TREASURER
Board
—
VANESSA SMITH
SECRETARY
Board
—
Details
EIN043543489
NTEE codeH99
Subsection03
Ruling date2001-06
Formed2001
Employees0